1,548 results on '"Park, Sang-Yoon"'
Search Results
2. Prospective analysis of pre and postoperative laboratory parameters associated with thrombosis in patients with ovarian cancer
3. Gene expression profiling of mucinous ovarian tumors and comparison with upper and lower gastrointestinal tumors identifies markers associated with adverse outcomes.
4. Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis
5. Randomized controlled trial of digital therapeutics for temporomandibular disorder: A pilot study
6. Advancements in computer-assisted orthognathic surgery: A comprehensive review and clinical application in South Korea
7. Expression patterns of AEG-1 in the normal brain
8. Synthesis of conducting polymer intercalated sodium vanadate nanofiber composites as active materials for aqueous zinc-ion batteries and NH3 gas sensors at room temperature
9. Anastomotic leakage after resection of the rectosigmoid colon in primary ovarian cancer
10. Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer
11. Current collectors of carbon fiber reinforced polymer for stackable energy storage composites
12. Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis
13. Impact of warm saline irrigation, hyperthermic intraperitoneal chemotherapy on postoperative pain in primary ovarian cancer from the KOV-HIPEC-01 randomized trial
14. Patient-specific plates for facial fracture surgery: A retrospective case series
15. Effect of corrosion inhibitors on SA106 Grade B carbon steel in H2SO4-N2H4 solution for the hydrazine-based reductive metal ion decontamination process
16. High-temperature electrochemical corrosion behavior of SA106 Grade B carbon steel with corrosion inhibitors in HyBRID solution
17. The quinone-based conjugated microporous polymer as an effective electrode additive for activated graphene host material in lithium-sulfur batteries
18. Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer.
19. Cost-effectiveness of hyperthermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III-IV ovarian cancer from a randomized controlled phase III trial in Korea (KOV-HIPEC-01)
20. CNT ink as an electrode additive for an effective hybrid conductive network in silicon microparticle/graphite anodes
21. Cytoreductive Surgery
22. Humidity-tolerant porous polymer coating for passive daytime radiative cooling
23. Redox-active conjugated microporous anthraquinonylamine-based polymer network grafted with activated graphene toward high-performance flexible asymmetric supercapacitor electrodes
24. Cell-type continuous electromagnetic radiation system generating millimeter waves for active denial system applications
25. A calculation of the neutron endurance for Al2O3/SS316L
26. Surgical outcomes of ureteral reconstruction during cytoreductive surgery for ovarian cancer: a retrospective cohort study
27. A predictive model based on site-specific risk factors of recurrence regions in endometrial cancer patients
28. Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors.
29. Reinforced nitrogen oxide gas adsorption by sulfur ionic treatment
30. Efficient adsorption of sulfide gas using porous zeolite powder
31. Second primary colorectal cancer among endometrial cancer survivor: shared etiology and treatment sequelae
32. A Comparative Analysis of Artificial Intelligence and Manual Methods for Three-Dimensional Anatomical Landmark Identification in Dentofacial Treatment Planning
33. Conversion of N-doped biochar from carotenoid-extracted Tetraselmis suecica and its application to produce supercapacitors
34. Impact of PARP inhibitor on QOL including nausea and vomiting per diem in ovarian cancer patients: prospective observational study
35. Final primary analysis in the original cohort of KGOG3046/TRU-D: a phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer
36. Efficacy of Immune-Checkpoint Inhibitors Combined with Cytotoxic Chemotherapy in Advanced or Recurrent Endometrial Cancer: A Systematic Review and Meta-Analysis
37. Preoperative laboratory parameters associated with deep vein thrombosis in patients with ovarian cancer: retrospective analysis of 3,147 patients in a single institute
38. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial
39. Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study
40. Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial
41. Room temperature manufacturing photoluminescent graphene quantum dots based on MXene
42. A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer
43. Thermal effects of copper-graphene composite films in a human skin analogous for the application to clothing
44. Conversion of N-doped biochar from carotenoid-extracted Tetraselmis suecica and its application to produce supercapacitors
45. Salvage surgery with second free flap reconstruction for recurrent oral squamous cell carcinoma
46. Analysis of effects of process factors on corrosion resistance of adhesive bonded joints for aluminum alloys
47. Prognostic value of CA125 kinetics, half-life, and nadir in the treatment of epithelial ovarian cancer: a systematic review and meta-analysis
48. Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin
49. TP017/#812 A phase III randomized controlled trial in primary stage three and four ovarian cancer after interval cytoreductive surgery (FOCUS/KOV-HIPEC-04)
50. TP018/#822 A randomized, multicenter, open-label phase III trial of hyperthermic intraperitoneal chemotherapy in platinum-resistant recurrent ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.